![Frontiers | Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in Precision Pediatric Oncology Frontiers | Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in Precision Pediatric Oncology](https://www.frontiersin.org/files/Articles/481902/fonc-09-00930-HTML/image_m/fonc-09-00930-g001.jpg)
Frontiers | Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in Precision Pediatric Oncology
![Frontiers | SPECT-CT Imaging of Dog Spontaneous Diffuse Large B-Cell Lymphoma Targeting CD22 for the Implementation of a Relevant Preclinical Model for Human Frontiers | SPECT-CT Imaging of Dog Spontaneous Diffuse Large B-Cell Lymphoma Targeting CD22 for the Implementation of a Relevant Preclinical Model for Human](https://www.frontiersin.org/files/Articles/484404/fonc-10-00020-HTML/image_m/fonc-10-00020-g001.jpg)
Frontiers | SPECT-CT Imaging of Dog Spontaneous Diffuse Large B-Cell Lymphoma Targeting CD22 for the Implementation of a Relevant Preclinical Model for Human
![Frontiers | Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in Precision Pediatric Oncology Frontiers | Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in Precision Pediatric Oncology](https://www.frontiersin.org/files/Articles/481902/fonc-09-00930-HTML/image_m/fonc-09-00930-t001.jpg)
Frontiers | Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in Precision Pediatric Oncology
![PDF) Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas—Retrospective Analysis of Three Real-Life Clinical Cases—Addressing Issues on Randomization and Customization at the Bedside PDF) Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas—Retrospective Analysis of Three Real-Life Clinical Cases—Addressing Issues on Randomization and Customization at the Bedside](https://i1.rgstatic.net/publication/339110101_Comprehensive_Molecular_Profiling_for_RelapsedRefractory_Pediatric_Burkitt_Lymphomas-Retrospective_Analysis_of_Three_Real-Life_Clinical_Cases-Addressing_Issues_on_Randomization_and_Customization_at_th/links/5e3e10c292851c7f7f25fbbd/largepreview.png)
PDF) Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas—Retrospective Analysis of Three Real-Life Clinical Cases—Addressing Issues on Randomization and Customization at the Bedside
![Frontiers | Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma Frontiers | Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma](https://www.frontiersin.org/files/Articles/478404/fonc-09-01169-HTML/image_m/fonc-09-01169-g001.jpg)
Frontiers | Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma
![Frontiers | Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy Frontiers | Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy](https://www.frontiersin.org/files/MyHome%20Article%20Library/447369/447369_Thumb_400.jpg)
Frontiers | Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy
![Frontiers | Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy Frontiers | Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy](https://www.frontiersin.org/files/Articles/447369/fonc-09-01221-HTML/image_m/fonc-09-01221-g002.jpg)